$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 2, 2025)
$29.44M
Market Cap
-
P/E Ratio
-0.79
EPS
$10.84
52 Week High
$1.75
52 Week Low
INDUSTRIALS
Sector
Sector: INDUSTRIALS
Industry: POLLUTION & TREATMENT CONTROLS
Rain Enhancement Technologies Holdco, Inc. is a clinical-stage precision oncology firm headquartered in Newark, California, focused on developing cutting-edge therapies that specifically target oncogenic drivers in cancer treatment. The company boasts a promising pipeline of innovative therapeutic candidates, utilizing advanced research methodologies and clinical insights to optimize patient outcomes. By addressing critical unmet needs in oncology, Rain Therapeutics is well-positioned to leverage the growing demand for targeted therapies in the evolving biopharmaceutical landscape, appealing to institutional investors seeking opportunities in the oncology sector.
LPTX
BYND
NVDA
INTC
PLRZ
VHAI
PLUG
BITF
IREN
IPG
TSLA
AAL
ASST
SOFI
JSPR
F
ADAP
WBD
MARA
BAC
DNN
PFE
NIO
AMD
CAN
CLSK
BTBT
MRVL
IVP
ITUB
CIFR
GOOGL
PLTR
GRAB
APLD
WULF
MSTR
PLTD
KVUE
T
SGMO
VALE
EB
HBAN
RGTI
ASBP
SNAP
MTSR
RIG
NFLX
PCG
HOOD
GOOG
VICI
VZ
TMC
BA
AG
AVGO
SOUN
RIOT
STLA
HL
XYZ
NOK
LUMN
KO
LPTX
BYND
NVDA
INTC
PLRZ
VHAI
PLUG
BITF
IREN
IPG
TSLA
AAL
ASST
SOFI
JSPR
F
ADAP
WBD
MARA
BAC
DNN
PFE
NIO
AMD
CAN
CLSK
BTBT
MRVL
IVP
ITUB
CIFR
GOOGL
PLTR
GRAB
APLD
WULF
MSTR
PLTD
KVUE
T
SGMO
VALE
EB
HBAN
RGTI
ASBP
SNAP
MTSR
RIG
NFLX
PCG
HOOD
GOOG
VICI
VZ
TMC
BA
AG
AVGO
SOUN
RIOT
STLA
HL
XYZ
NOK
LUMN
KO